Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 4/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.39 |
| ▸ | SQOR | Q9Y6N5 | 2/20 | 0.37 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KDM5B | Q9UGL1 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23348278 | 0.94 | PGR (0.39) | ADORA1ADORA2ASQORADORA2BPGR | |
| SCHEMBL23348520 | 0.94 | KDM5B (0.36) | ADORA1MEN1KMT2AKDM5BSMN1; SMN2 | |
| SCHEMBL23348461 | 0.93 | PGR (0.36) | ADORA1ADORA2ASQORNR3C1ADORA2B | |
| SCHEMBL23348464 | 0.90 | SQOR (0.35) | ADORA1ADORA2ASQORNR3C1ADORA2B | |
| SCHEMBL22155921 | 0.89 | PGR (0.41) | ADORA1ADORA2ASQORADORA2BPGR | |
| SCHEMBL22155922 | 0.89 | PGR (0.39) | ADORA1ADORA2ASQORNR3C1ADORA2B | |
| SCHEMBL22155914 | 0.88 | PGR (0.37) | ADORA1ADORA2ASQORADORA2BPGR | |
| SCHEMBL22155913 | 0.88 | PGR (0.39) | ADORA1ADORA2ASQORADORA2BPGR | |
| SCHEMBL22155854 | 0.88 | ADORA1 (0.43) | ADORA1ADORA2AADORA2BPGRKDM4E | |
| SCHEMBL23348279 | 0.87 | SMN1; SMN2 (0.33) | PGRMEN1KMT2AKDM5BSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139425-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCND2, CCND1, CRY1 | ADORA1 2252/4885ADORA2A 2152/4885SQOR 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.